236 related articles for article (PubMed ID: 16564009)
41. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
42. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
Puhar A; Montecucco C
Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
[TBL] [Abstract][Full Text] [Related]
43. Structural biology: anthrax hijacks host receptor.
Bann JG; Hultgren SJ
Nature; 2004 Aug; 430(7002):843-4. PubMed ID: 15318206
[No Abstract] [Full Text] [Related]
44. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
45. Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors.
Abrami L; Bischofberger M; Kunz B; Groux R; van der Goot FG
PLoS Pathog; 2010 Mar; 6(3):e1000792. PubMed ID: 20221438
[TBL] [Abstract][Full Text] [Related]
46. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
[TBL] [Abstract][Full Text] [Related]
47. EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin.
Lu Q; Wei W; Kowalski PE; Chang AC; Cohen SN
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17246-51. PubMed ID: 15569923
[TBL] [Abstract][Full Text] [Related]
48. Detection of endogenous LRP6 expressed on human cells by monoclonal antibodies specific for the native conformation.
Yasui N; Mihara E; Nampo M; Tamura-Kawakami K; Unno H; Matsumoto K; Takagi J
J Immunol Methods; 2010 Jan; 352(1-2):153-60. PubMed ID: 19945460
[TBL] [Abstract][Full Text] [Related]
49. Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitor.
Kong Y; Guo Q; Yu C; Dong D; Zhao J; Cai C; Hou L; Song X; Fu L; Xu J; Chen W
FEBS Lett; 2009 Apr; 583(8):1257-60. PubMed ID: 19332063
[TBL] [Abstract][Full Text] [Related]
50. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
51. Functional characterization of peptide-based anthrax toxin inhibitors.
Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
[TBL] [Abstract][Full Text] [Related]
52. Anthrax toxin rafts into cells.
Kurzchalia T
J Cell Biol; 2003 Feb; 160(3):295-6. PubMed ID: 12566425
[TBL] [Abstract][Full Text] [Related]
53. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
Liu S; Leppla SH
J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
[TBL] [Abstract][Full Text] [Related]
54. Manipulation of host signalling pathways by anthrax toxins.
Turk BE
Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
[TBL] [Abstract][Full Text] [Related]
55. Enhanced exocytosis of the receptor BT-R(1) induced by the Cry1Ab toxin of Bacillus thuringiensis directly correlates to the execution of cell death.
Zhang X; Griko NB; Corona SK; Bulla LA
Comp Biochem Physiol B Biochem Mol Biol; 2008 Apr; 149(4):581-8. PubMed ID: 18230416
[TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
58. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli.
Ding Z; Bradley KA; Amin Arnaout M; Xiong JP
Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009
[TBL] [Abstract][Full Text] [Related]
59. Evidence against a human cell-specific role for LRP6 in anthrax toxin entry.
Ryan PL; Young JA
PLoS One; 2008 Mar; 3(3):e1817. PubMed ID: 18350154
[TBL] [Abstract][Full Text] [Related]
60. Anthrax lethal and edema toxins fail to directly impair human platelet function.
Chauncey KM; Szarowicz SE; Sidhu GS; During RL; Southwick FS
J Infect Dis; 2012 Feb; 205(3):453-7. PubMed ID: 22158563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
